ARSH SINGH, M.D.
Medical Oncology Physician · PORT CHARLOTTE, FL
Individual Active NPI 1063712826
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,879 | 395,492 | $19,067,927 | $6,979,103 | $5,558,254 |
| 2023 | 1,731 | 364,334 | $17,337,961 | $5,870,132 | $4,674,188 |
| 2022 | 1,405 | 276,959 | $13,250,896 | $4,698,447 | $3,764,821 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 73,950 | $0 | $0 |
| J1756 | Injection, iron sucrose, 1 mg | 31,800 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 19,800 | $55 | $44 |
| J9025 | Injection, azacitidine, 1 mg | 15,400 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 14,180 | $31 | $25 |
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 11,880 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 10,260 | $49 | $39 |
| J0185 | Injection, aprepitant, 1 mg | 9,100 | $2 | $1 |
| J0897 | Injection, denosumab, 1 mg | 7,800 | $26 | $21 |
| J2182 | Injection, mepolizumab, 1 mg | 7,000 | $30 | $24 |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 6,583 | $8 | $6 |
| J9267 | Injection, paclitaxel, 1 mg | 6,427 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | ME120742 | FL |
| Hematology (Internal Medicine) Physician | 207RH0000X | ME120742 | FL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Florida
- NPI 1073571949
- NPI 1942649769
- NPI 1619053998
- NPI 1346636636
- NPI 1578444758
- NPI 1528059227
- NPI 1215101902
- NPI 1861729170
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.